Gynecologic Cancers

Latest News

PARP Inhibitors May Be a Promising Treatment Strategy in Advanced Uterine Leiomyosarcoma
PARP Inhibitors May Be a Promising Treatment Strategy in Advanced Uterine Leiomyosarcoma

September 18th 2023

Kjersten Dosumu, DNP, MS, AGPCNP-BC, explains why investigators are optimistic about treating uterine leiomyosarcoma with olaparib and temozolomide.

Niraparib Maintenance Reduces Progression in Newly Diagnosed Ovarian Cancer
Niraparib Maintenance Reduces Progression in Newly Diagnosed Ovarian Cancer

September 2nd 2023

 Relacorilant Plus Nab-Paclitaxel Improves OS, But Not PFS, in Recurrent, Platinum-Resistant Ovarian Cancer
Relacorilant Plus Nab-Paclitaxel Improves OS, But Not PFS, in Recurrent, Platinum-Resistant Ovarian Cancer

August 8th 2023

gynecologic cancer
Olaparib Plus Temozolomide Induces Modest Results in Advanced Uterine Leiomyosarcoma

August 4th 2023

FDA
FDA Approves Frontline Dostarlimab in Combination With Chemotherapy for dMMR/MSI-H Endometrial Cancer

July 31st 2023

Latest CME Events & Activities

2nd Annual International Congress on Pediatric Oncology

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

9th Annual School of Gastrointestinal Oncology® (SOGO®)

Register Now!

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Register Now!

BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS

View More

BURST CME™: What Is the Real Risk in Lower-Risk MDS?

View More

BURST CME™: How Does Transfusion Burden Impact Real-World Outcomes in MDS?

View More

The Latest on Acute Lymphocytic Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

A Focus on Acute Myeloid Leukemia

View More

Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Medical Crossfire®: Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

View More

25th Annual International Lung Cancer Congress®

Register Now!

Community Practice Connections™: Multidisciplinary Strategies for Improving Outcomes in CML from Frontline Care… and Beyond!

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

7th Annual School of Nursing Oncology™

View More

Crucial Conversations in R/R Multiple Myeloma: Nursing Strategies to Optimize Patient Communication and Improve Outcomes

View More

GlobaOncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of B-Cell Lymphomas with BTK Inhibitors

View More

Myeloma Management Considerations: Applying the Evidence With Monoclonal Antibody Based Regimens

View More

More News

© 2023 MJH Life Sciences

All rights reserved.